HAOHAI BIOTEC (06826) has repurchased a total of 662,500 A-shares until the end of February.
Hao Hai Biotechnology (06826) announced that in February 2025, the company did not implement any share repurchases. As of 202...
HAOHAI BIOTEC (06826) announced that in February 2025, the company did not implement any share repurchases. As of February 28, 2025, the company had repurchased a total of 662,500 A shares through centralized bidding transactions, accounting for 0.28% of the company's total share capital of 233 million shares. The highest transaction price was 63.58 yuan per share, the lowest transaction price was 56.78 yuan per share, and the total transaction amount was 40.5364 million yuan (excluding stamp duty, transaction commission, and other transaction fees).
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


